ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666571 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666571; 2) Community: the network communities that were significantly associated with the response to NSC 666571; 3) Molecule: the relationships between components within communities and NSC 666571; 4) MDR: the compounds that were significantly associated with the NSC 666571.

NSC Compound Enrichment Correlation
NSC 626880 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-hydroxy- phenyl)methylene]-, hydrochloride 0.0171490505199913 0.34799841
NSC 649811 2H-1-Benzopyran-3-acetamide, N-(3-chloro-1,4-dioxo- 2-naphthyl)-4-hydroxy-.beta.,2-dioxo- 0.0171490505199913 0.37475321
NSC 657299 Null 0.0171490505199913 0.44318452
NSC 671043 2-Ethoxyestra-1,3,5-trien-3,17.beta.-diol 0.0171490505199913 0.71219187
NSC 715224 Null 0.0171490505199913 0.30305105
NSC 753193 N-(2-(4-acetylpiperazin-1-yl)ethyl)-3-(3-chloro-5-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazole-1-carboxamide 0.0171490505199913 0.36874533
NSC 150446 Berberine iodide 0.0178844438004194 0.17230968
NSC 321237 Mercury, (4-aminophenyl)(6-thioguanosinato-N7,S6)- 0.0178844438004194 0.43927782
NSC 341936 Adenosine, 2-bromo-2'-deoxy- 0.0178844438004194 0.27112942
NSC 606985 Camptothecin Derivative 0.0178844438004194 0.028253691
Total:78  Current:32    [First] [Prev] [Next] [Last]